Tarsorrhaphy: applications in a Cornea Service

To evaluate the main indications for tarsorrhaphy in a Corneal Service, as well as success rate and possible complications. All patients who underwent tarsorrhaphy from January 1st, 2002 to December 30th, 2002, in São Geraldo Eye Hospital - Federal University of Minas Gerais were evaluated retrospec...

Full description

Saved in:
Bibliographic Details
Published inArquivos brasileiros de oftalmologia Vol. 68; no. 1; pp. 103 - 107
Main Authors Tzelikis, Patrick Frensel de Moraes, Diniz, Cristiano Menezes, Tanure, Marco Antônio Guarino, Trindade, Fernando Cançado
Format Journal Article
LanguagePortuguese
Published Brazil 01.01.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To evaluate the main indications for tarsorrhaphy in a Corneal Service, as well as success rate and possible complications. All patients who underwent tarsorrhaphy from January 1st, 2002 to December 30th, 2002, in São Geraldo Eye Hospital - Federal University of Minas Gerais were evaluated retrospectively. Reviewed data included patient's sex and age, indication for tarsorrhaphy, duration of signs and symptoms before tarsorrhaphy, time for epithelial healing after tarsorrhaphy, type of tarsorrhaphy, complications, follow-up time. Eighteen patients underwent tarsorrhaphy. The indications for a tarsorrhaphy were exposure keratopathy (27.8%), persistent epithelial defect associated with penetrating keratoplasty (38.8%), neurotrophic ulcer (11.1%), dry eye syndrome (5.6%), Stevens-Johnson syndrome (11.1%), and chemical burn (5.6%). The epithelial defect resolved completely in 15 patients (83.3%). Mean duration of signs and symptoms before tarsorrhaphy was 98.7+/-48.6 days, and time to heal after tarsorrhaphy was 53.2+/-22.8 days. Of the 18 procedures, two (11.1%) were temporary and 16 (88.9%) permanent. Complications after tarsorrhaphy were premature opening of the tarsorrhaphy, trichiasis and pyogenic granuloma. Tarsorrhaphy is a simple procedure, being also very safe and effective in the management of nonhealing epithelial defects, with a success rate of 83.3% and with minor complications.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0004-2749